170 related articles for article (PubMed ID: 17145757)
21. CDK5 phosphorylates eNOS at Ser-113 and regulates NO production.
Lee CH; Wei YW; Huang YT; Lin YT; Lee YC; Lee KH; Lu PJ
J Cell Biochem; 2010 May; 110(1):112-7. PubMed ID: 20213743
[TBL] [Abstract][Full Text] [Related]
22. Peroxiredoxin 5 Decreases Beta-Amyloid-Mediated Cyclin-Dependent Kinase 5 Activation Through Regulation of Ca
Park J; Kim B; Chae U; Lee DG; Kam MK; Lee SR; Lee S; Lee HS; Park JW; Lee DS
Antioxid Redox Signal; 2017 Oct; 27(11):715-726. PubMed ID: 28358580
[TBL] [Abstract][Full Text] [Related]
23. Cyclin-dependent kinase 5 regulates steroidogenic acute regulatory protein and androgen production in mouse Leydig cells.
Lin H; Chen MC; Ku CT
Endocrinology; 2009 Jan; 150(1):396-403. PubMed ID: 18755796
[TBL] [Abstract][Full Text] [Related]
24. Cyclin-dependent kinase 5 phosphorylates signal transducer and activator of transcription 3 and regulates its transcriptional activity.
Fu AK; Fu WY; Ng AK; Chien WW; Ng YP; Wang JH; Ip NY
Proc Natl Acad Sci U S A; 2004 Apr; 101(17):6728-33. PubMed ID: 15096606
[TBL] [Abstract][Full Text] [Related]
25. Activation of Cdk5/p25 and tau phosphorylation following chronic brain hypoperfusion in rats involves microRNA-195 down-regulation.
Sun LH; Ban T; Liu CD; Chen QX; Wang X; Yan ML; Hu XL; Su XL; Bao YN; Sun LL; Zhao LJ; Pei SC; Jiang XM; Zong DK; Ai J
J Neurochem; 2015 Sep; 134(6):1139-51. PubMed ID: 26118667
[TBL] [Abstract][Full Text] [Related]
26. Glucose-induced expression of the cyclin-dependent protein kinase 5 activator p35 involved in Alzheimer's disease regulates insulin gene transcription in pancreatic beta-cells.
Ubeda M; Kemp DM; Habener JF
Endocrinology; 2004 Jun; 145(6):3023-31. PubMed ID: 14976144
[TBL] [Abstract][Full Text] [Related]
27. Cyclin-dependent kinase five mediates activation of lung xanthine oxidoreductase in response to hypoxia.
Kim BS; Serebreni L; Fallica J; Hamdan O; Wang L; Johnston L; Kolb T; Damarla M; Damico R; Hassoun PM
PLoS One; 2015; 10(4):e0124189. PubMed ID: 25831123
[TBL] [Abstract][Full Text] [Related]
28. Knockdown of Expression of Cdk5 or p35 (a Cdk5 Activator) Results in Podocyte Apoptosis.
Zheng YL; Zhang X; Fu HX; Guo M; Shukla V; Amin ND; E J; Bao L; Luo HY; Li B; Lu XH; Gao YC
PLoS One; 2016; 11(8):e0160252. PubMed ID: 27479491
[TBL] [Abstract][Full Text] [Related]
29. Valproic acid downregulates Cdk5 activity via the transcription of the p35 mRNA.
Takahashi M; Ishida M; Saito T; Ohshima T; Hisanaga S
Biochem Biophys Res Commun; 2014 May; 447(4):678-82. PubMed ID: 24755075
[TBL] [Abstract][Full Text] [Related]
30. Overexpression of the NOTCH1 intracellular domain inhibits cell proliferation and alters the neuroendocrine phenotype of medullary thyroid cancer cells.
Kunnimalaiyaan M; Vaccaro AM; Ndiaye MA; Chen H
J Biol Chem; 2006 Dec; 281(52):39819-30. PubMed ID: 17090547
[TBL] [Abstract][Full Text] [Related]
31. Calpastatin, an endogenous calpain-inhibitor protein, regulates the cleavage of the Cdk5 activator p35 to p25.
Sato K; Minegishi S; Takano J; Plattner F; Saito T; Asada A; Kawahara H; Iwata N; Saido TC; Hisanaga S
J Neurochem; 2011 May; 117(3):504-15. PubMed ID: 21338355
[TBL] [Abstract][Full Text] [Related]
32. p35/Cdk5 pathway mediates soluble amyloid-beta peptide-induced tau phosphorylation in vitro.
Town T; Zolton J; Shaffner R; Schnell B; Crescentini R; Wu Y; Zeng J; DelleDonne A; Obregon D; Tan J; Mullan M
J Neurosci Res; 2002 Aug; 69(3):362-72. PubMed ID: 12125077
[TBL] [Abstract][Full Text] [Related]
33. Involvement of cAMP in nerve growth factor-triggered p35/Cdk5 activation and differentiation in PC12 cells.
Chen MC; Lin H; Hsu FN; Huang PH; Lee GS; Wang PS
Am J Physiol Cell Physiol; 2010 Aug; 299(2):C516-27. PubMed ID: 20463173
[TBL] [Abstract][Full Text] [Related]
34. Cyclin-dependent kinase 5 regulates degranulation in human eosinophils.
Odemuyiwa SO; Ilarraza R; Davoine F; Logan MR; Shayeganpour A; Wu Y; Majaesic C; Adamko DJ; Moqbel R; Lacy P
Immunology; 2015 Apr; 144(4):641-8. PubMed ID: 25346443
[TBL] [Abstract][Full Text] [Related]
35. Involvement of aberrant cyclin-dependent kinase 5/p25 activity in experimental traumatic brain injury.
Yousuf MA; Tan C; Torres-Altoro MI; Lu FM; Plautz E; Zhang S; Takahashi M; Hernandez A; Kernie SG; Plattner F; Bibb JA
J Neurochem; 2016 Jul; 138(2):317-27. PubMed ID: 26998748
[TBL] [Abstract][Full Text] [Related]
36. p39 Is Responsible for Increasing Cdk5 Activity during Postnatal Neuron Differentiation and Governs Neuronal Network Formation and Epileptic Responses.
Li W; Allen ME; Rui Y; Ku L; Liu G; Bankston AN; Zheng JQ; Feng Y
J Neurosci; 2016 Nov; 36(44):11283-11294. PubMed ID: 27807169
[TBL] [Abstract][Full Text] [Related]
37. Profiling of p5, a 24 Amino Acid Inhibitory Peptide Derived from the CDK5 Activator, p35 CDKR1 Against 70 Protein Kinases.
Binukumar BK; Pelech SL; Sutter C; Shukla V; Amin ND; Grant P; Bhaskar M; Skuntz S; Steiner J; Pant HC
J Alzheimers Dis; 2016 Sep; 54(2):525-33. PubMed ID: 27567857
[TBL] [Abstract][Full Text] [Related]
38. Cyclin-dependent kinase 5 activity regulates pain signaling.
Pareek TK; Keller J; Kesavapany S; Pant HC; Iadarola MJ; Brady RO; Kulkarni AB
Proc Natl Acad Sci U S A; 2006 Jan; 103(3):791-6. PubMed ID: 16407116
[TBL] [Abstract][Full Text] [Related]
39. Phosphorylation of p35 and p39 by Cdk5 determines the subcellular location of the holokinase in a phosphorylation-site-specific manner.
Asada A; Saito T; Hisanaga S
J Cell Sci; 2012 Jul; 125(Pt 14):3421-9. PubMed ID: 22467861
[TBL] [Abstract][Full Text] [Related]
40. Two Degradation Pathways of the p35 Cdk5 (Cyclin-dependent Kinase) Activation Subunit, Dependent and Independent of Ubiquitination.
Takasugi T; Minegishi S; Asada A; Saito T; Kawahara H; Hisanaga S
J Biol Chem; 2016 Feb; 291(9):4649-57. PubMed ID: 26631721
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
